Embracing Genetic Diversity of iPSC-based Neuroinflammation Models for Robust Drug Discovery
Time: 12:10 pm
day: Day One
Details:
• Developing iPSC panels to account for distinct disease origins and diverse patient genomic background in drug discovery
• Leveraging data on protective genomic variants to bolster prioritization of therapeutically relevant disease modifiers
• Catalyzing discovery of neuroinflammation modulators for neurodegeneration using therapeutic oligonucleotides
